Seroprevalence of Hepatitis B Infection among First-Time Blood Donors in Faridpur, Bangladesh: A Cross-sectional Study
Keywords:Hepatitis B, Blood Transfusion, Blood Donors, Bangladesh
Background: Hepatitis B infection is a global threat for people of all age groups and is common in Bangladesh and other South Asian countries. Blood donors and blood donation can present important risk for hepatitis B infection. Our objective was to identify seroprevalence of hepatitis B virus among blood donors in Faridpur, Bangladesh.
Methods: A cross-sectional study was conducted among 719 blood donors in the Faridpur district of Bangladesh from April to July 2013. Data was collected by non-probability convenient sampling maintaining inclusion and exclusion criteria. Face-to-face interview, blood grouping test, and hepatitis B surface antigen (HBsAg) screening were conducted.
Results: About 30% of the blood donors were between 19 and 23 years of age, and 87.5% of them were males. Two-thirds (64.1%) of the donors were replacement donors, while the remaining 35.9% of them were voluntary donors. The overall seropositivity of HBsAg was found to be 1.5%. All infected blood donors were males. Hepatitis B infection was more prevalent in the 34–38 years age group and least prevalent among those older than 48 years of age. About 2% of replacement blood donors were infected with hepatitis B virus, compared to 0.7% among voluntary blood donors.
Conclusion: Hepatitis B infection among blood donors is relatively lower than in other high-risk groups for hepatitis B infection in Bangladesh. Predominance of HBsAg among older adult groups, replacement donors, and the male gender can be a matter of public health concern.
2. Mahtab MA, Rahman S, Karim MF, Khan M, Foster G, Solaiman S, et al. Epidemiology of hepatitis B virus in Bangladeshi general population. Hepato¬biliary Pancreat Dis Int. 2008 Dec;7(6):595-600.
3. Khan M, Ahmed N. Seroepidemiology of HBV and HCV in Bangladesh [abs¬tract]. Int Hepatol Commun. 1996 May;5(1):27-9.
4. Deinhardt F. Serum markers of hepatitis viruses in natural disease and after vaccination. Prog Liver Dis. 1982;7:451-67.
5. Islam MN, Islam KM, Islam N. Hepatitis-B virus infection in Dhaka, Bangla¬desh. Bangladesh Med Res Counc Bull. 1984 Jun;10(1):1-6.
6. Rumi MA, Begum K, Hassan MS, Hasan SM, Azam MG, Hasan KN, et al. De¬tection of hepatitis B surface antigen in pregnant women attending a public hospital for delivery: implication for vaccination strategy in Bangladesh. Am J Trop Med Hyg. 1998 Aug;59(2):318-22.
7. Mustafa M, Islam MN, Rahman M, Salauddin AK. Prevalence of hepatitis B surface antigen (HBsAg) among parenteral drug abusers at Dhaka. Bangla¬desh Med Res Counc Bull. 1989 Jun;15(1):1-7.
8. Ahmad Q, Chowdhury SG, Islam MN, Khan FD, Alam MR, Miah AH. HBsAg
amongst unscreened operated patients. Bangladesh Med Res Counc Bull. 1991 Jun;17(1):11-6.
9. Sattar H, Islam MN. Hepatitis B virus markers among the prostitutes of Dhaka. Bangladesh Med Res Counc Bull. 1996 Apr;22(1):8-11.
10. Khan WI, Sultana R, Rahman M, Akhter H, Haq JA, Ali L, et al. Viral hepa¬titis: recent experiences from serological studies in Bangladesh. Asian Pac J Allergy Immunol. 2000 Jun;18(2):99-103.
11. Sabin KM, Rahman M, Hawkes S, Ahsan K, Begum L, Black RE, et al. Sexua¬lly transmitted infections prevalence rates in slum communities of Dhaka, Bangladesh. Int J STD AIDS. 2003 Sep;14(9):614-21.
12. Rumi MA, Siddiqui MA, Salam MA, Iqbal MR, Azam MG, Chowdhury AK, et al. Prevalence of infectious diseases and drug abuse among Bangladeshi workers. Southeast Asian J Trop Med Public Health. 2000 Sep;31(3):571-4.
13. Rahman M, Amanullah, Sattar H, Rahman M, Rashid HA, Mollah AS. Se¬ro-epidemiological study of hepatitis B virus infection in a village. Bangla¬desh Med Res Counc Bull. 1997 Aug;23(2):38-41.
14. Khan M, Haq SA, Ahmed N, Matin MA. Etiology and clinical profile of hepatocellular carcinoma in Bangladesh. Bangladesh Med Res Counc Bull. 1997 Apr;23(1):16-24.
15. Hawkes S. Commentary: Human immunodeficiency virus and hepatitis in Bangladesh: widespread or targeted prevention strategies? Int J Epidemiol. 2001 Aug;30(4):885-6.
16. Laskar MS, Harada N, Khan F. Prevalence of hepatitis B surface antigen (HBsAg) in Viqarunnessa noon girls' school children in Dhaka, Bangladesh. Cent Eur J Public Health. 1997 Dec;5(4):202-4.
17. Ashraf H, Alam NH, Rothermundt C, Brooks A, Bardhan P, Hossain L, et al. Prevalence and risk factors of hepatitis B and C virus infections in an impoverished urban community in Dhaka, Bangladesh. BMC Infect Dis. 2010 Jul 15;10:208.
18. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Stu¬dies in Epidemiology (STROBE) statement: guidelines for reporting observa¬tional studies. PLoS Med. 2007 Oct 16;4(10):e296.
19. Rudra S, Chakrabarty P, Hossain MA, Akhter H, Bhuiyan MR. Seropreva¬lence of hepatitis B, hepatitis C, HIV infections in blood donors of Khulna, Bangladesh. Mymensingh Med J. 2010 Oct;19(4):515-9.
20. Dewan G. Prevalence of hepatitis B and C virus seropositivity among tribal and non-tribal voluntary blood donors of Rangamati, Bangladesh. J Univers Coll of Med Sci. 2013;1(4):33-6.
21. Gibney L, Saquib N, Metzger J, Choudhury P, Siddiqui M, Hassan M. Hu¬man immunodeficiency virus, hepatitis B, C and D in Bangladesh's trucking industry: prevalence and risk factors. Int J Epidemiol. 2001 Aug;30(4):878-84.
22. Shirin T, Ahmed T, Iqbal A, Islam M, Islam MN. Prevalence and risk fac¬tors of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infections among drug addicts in Bangladesh. J Health Popul. Nutr. 2000 Dec;18(3):145-50.
23. de Francisco A, Hall AJ, Alam N, Hawkes S, Azim T. Hepatitis B infection in Bangladeshi mothers and infants. Southeast Asian J Trop Med Public Health. 1999 Jun;30(2):296-8.
24. Agarwal N, Chatterjee K, Coshic P, Borgohain M. Nucleic acid testing for blood banks: an experience from a tertiary care centre in New Delhi, India. Transfus Apher Sci. 2013 Dec;49(3):482-4.
25. Zaheer HA, Saeed U, Waheed Y, Karimi S, Waheed U. Prevalence and trends of hepatitis B, hepatitis C and human immunodeficiency viruses among blood donors in Islamabad, Pakistan 2005-2013. J Blood Disord Transf. 2014;5(6):217.
26. Liu GC, Sui GY, Liu GY, Zheng Y, Deng Y, Gao YY, et al. A Bayesian me¬ta-analysis on prevalence of hepatitis B virus infection among Chinese vo¬lunteer blood donors. PloS One. 2013 Nov 13;8(11):e79203.
27. Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of world¬wide prevalence of chronic hepatitis B virus infection: a systematic review of
data published between 1965 and 2013. Lancet. 2015 Oct 17;386(10003):1546- 55.
28. Pandeya DR. P3.253 Sero prevalence of HIV, hepatitis B, hepatitis C and syphilis among blood donors in Kathmandu, Nepal. Sex Transm Infect. 2013;89(Suppl 1):A227-8.
29. Ahad MA, Bakar MA, Nazmul Ahsan HA. Pattern of ABO and Rhesus(Rh) blood group among blood donors. J Teach Assoc. 2002;15(2):68-70.
30. Talukder SI, Das RK. Distribution of ABO and Rh blood groups among blood donors of Dinajpur district of Bangladesh. Dinajpur Med Coll J. 2010 Jul;3(2):55-8.
31. Sultana R, Rahman Z, Helali AM, Yousuf R, Mustafa S, Salam A, et al. Study Of ABO and Rh-D blood groups among the common people of capital city of Bangladesh. Int J Pharm Pharm Sci. 2013;5(3):814-6.
How to Cite
Authors who publish with this journal agree to the following terms:
- The Author retains copyright in the Work, where the term “Work” shall include all digital objects that may result in subsequent electronic publication or distribution.
- Upon acceptance of the Work, the author shall grant to the Publisher the right of first publication of the Work.
- The Author shall grant to the Publisher and its agents the nonexclusive perpetual right and license to publish, archive, and make accessible the Work in whole or in part in all forms of media now or hereafter known under a Creative Commons Attribution 4.0 International License or its equivalent, which, for the avoidance of doubt, allows others to copy, distribute, and transmit the Work under the following conditions:
- Attribution—other users must attribute the Work in the manner specified by the author as indicated on the journal Web site; with the understanding that the above condition can be waived with permission from the Author and that where the Work or any of its elements is in the public domain under applicable law, that status is in no way affected by the license.
- The Author is able to enter into separate, additional contractual arrangements for the nonexclusive distribution of the journal's published version of the Work (e.g., post it to an institutional repository or publish it in a book), as long as there is provided in the document an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post online a prepublication manuscript (but not the Publisher’s final formatted PDF version of the Work) in institutional repositories or on their Websites prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. Any such posting made before acceptance and publication of the Work shall be updated upon publication to include a reference to the Publisher-assigned DOI (Digital Object Identifier) and a link to the online abstract for the final published Work in the Journal.
- Upon Publisher’s request, the Author agrees to furnish promptly to Publisher, at the Author’s own expense, written evidence of the permissions, licenses, and consents for use of third-party material included within the Work, except as determined by Publisher to be covered by the principles of Fair Use.
- The Author represents and warrants that:
- the Work is the Author’s original work;
- the Author has not transferred, and will not transfer, exclusive rights in the Work to any third party;
- the Work is not pending review or under consideration by another publisher;
- the Work has not previously been published;
- the Work contains no misrepresentation or infringement of the Work or property of other authors or third parties; and
- the Work contains no libel, invasion of privacy, or other unlawful matter.
- The Author agrees to indemnify and hold Publisher harmless from the Author’s breach of the representations and warranties contained in Paragraph 6 above, as well as any claim or proceeding relating to Publisher’s use and publication of any content contained in the Work, including third-party content.
Enforcement of copyright
The IJMS takes the protection of copyright very seriously.
If the IJMS discovers that you have used its copyright materials in contravention of the license above, the IJMS may bring legal proceedings against you seeking reparation and an injunction to stop you using those materials. You could also be ordered to pay legal costs.
If you become aware of any use of the IJMS' copyright materials that contravenes or may contravene the license above, please report this by email to email@example.com
If you become aware of any material on the website that you believe infringes your or any other person's copyright, please report this by email to firstname.lastname@example.org